Ozempic® 0.25mg is a prescription GLP-1 receptor agonist containing semaglutide, designed as the starting dose for adults beginning treatment for type 2 diabetes. Administered as a once-weekly injection, it helps the body gradually adjust to the medication, reducing the likelihood of gastrointestinal side effects before increasing to higher maintenance doses. The 0.25mg dose is intended for treatment initiation and is typically used for the first four weeks before progressing to 0.5mg, as directed by a healthcare provider.
Key Benefits
- Once-weekly, easy-to-use injectable pen
- Supports blood sugar management in adults with type 2 diabetes
- Helps the body adapt to semaglutide therapy before dose escalation
- May help reduce appetite and support weight loss under medical supervision
- Convenient pre-filled injection pen
Important: Ozempic is a prescription-only medicine and should only be used under the guidance of a qualified healthcare professional. It is not suitable for everyone and should not be used by people with type 1 diabetes or those with a personal or family history of certain thyroid cancers. Always follow your healthcare provider’s dosing instructions and read the patient information leaflet before use.
Reviews
There are no reviews yet.